Skip to main content
[Preprint]. 2022 Jan 26:2022.01.03.474779. Originally published 2022 Jan 4. [Version 3] doi: 10.1101/2022.01.03.474779

Figure 4.

Figure 4.

CSNK2 target validation. (A) Relative expression after MHV infection of the CSNK2 subunit mRNAs in DBT cells by qRT-PCR. (B) Expression of CSNK2 subunits by Western blot after siRNA targeting. DBT, untreated cells. NT, non-targeting control siRNA. C. Inhibition of MHV replication by siRNA knockdown of CSNK2 subunits. * p < 0.05, *** p < 0.001.